Anal cancer and its precursors in HIV-positive patients: Perspectives and management

Surgical Oncology Clinics of North America

Volumn 13, Issue 2, 2004, Pages 355-373

  Berry, J Michael ^a   Palefsky, Joel M ^a   Welton, Mark Lane ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; FLUOROURACIL; MITOMYCIN C;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANUS CARCINOMA; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BOWEN DISEASE; CANCER COMBINATION CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SCREENING; CARCINOMA IN SITU; CLINICAL FEATURE; COLPOSCOPY; DISEASE ASSOCIATION; DRUG CYTOTOXICITY; DYSPLASIA; ELECTROSURGERY; GASTROINTESTINAL TOXICITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPHOCYTE COUNT; NEUTROPENIA; PAPANICOLAOU TEST; RADIATION DOSE FRACTIONATION; REVIEW; SEXUAL BEHAVIOR; SKIN EXFOLIATION; SKIN TOXICITY; SURVIVAL RATE; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANUS NEOPLASMS; CARCINOMA IN SITU; COMBINED MODALITY THERAPY; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 2342561043     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2003.12.003     Document Type: Review

References (45)

1. Melbye M., Rabkin C., Frisch M., Biggar R.J. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol. 139:(8):1994;772-780
2. Frisch M., Biggar R.J., Goedert J.J. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 92:(18):2000;1500-1510
3. Frisch M., Glimelius B., van den Brule A.J., Wohlfahrt J., Meijer C.J., Walboomers J.M., et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 337:(19):1997;1350-1358
4. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 348:(6):2003;518-527
5. Ogunbiyi O.A., Scholefield J.H., Raftery A.T., Smith J.H., Duffy S., Sharp F., et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg. 81:(3):1994;365-367
6. Adami J., Gabel H., Lindelof B., Ekstrom K., Rydh B., Glimelius B., et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer. 89:(7):2003;1221-1227
7. Cress R.D., Holly E.A. Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973-1999. Prev Med. 36:(5):2003;555-560
8. Frisch M., Smith E., Grulich A., Johansen C. Cancer in a population-based cohort of men and women in registered homosexual partnerships. Am J Epidemiol. 157:(11):2003;966-972
9. Piketty C., Darragh T.M., Da Costa M., Bruneval P., Heard I., Kazatchkine M.D., et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med. 138:(6):2003;453-459
10. Mbulaiteye S.M., Biggar R.J., Goedert J.J., Engels E.A. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr. 32:(5):2003;527-533
11. Palefsky J.M., Holly E.A. Immunosuppression and co-infection with HIV [chapter 6]. J Natl Cancer Inst Monogr. (31):2003;41-46
12. Goldie S.J., Kuntz K.M., Weinstein M.C., Freedberg K.A., Welton M.L., Palefsky J.M. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA. 281:(19):1999;1822-1829
13. Goldie S.J., Kuntz K.M., Weinstein M.C., Freedberg K.A., Palefsky J.M. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med. 108:(8):2000;634-641
14. Palefsky J.M., Holly E.A., Hogeboom C.J., Berry J.M., Jay N., Darragh T.M. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol. 14:(5):1997;415-422
15. Darragh T.M., Jay N., Tupkelewicz B.A., Hogeboom C.J., Holly E.A., Palefsky J.M. Comparison of conventional cytologic smears and ThinPrep preparations from the anal canal. Acta Cytol. 41:(4):1997;1167-1170
16. Wright T.C. Jr., Cox J.T., Massad L.S., Twiggs L.B., Wilkinson E.J. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 287:(16):2002;2120-2129
17. Jay N., Berry J.M., Hogeboom C.J., Holly E.A., Darragh T.M., Palefsky J.M. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum. 40:(8):1997;919-928
18. Litle V.R., Leavenworth J.D., Darragh T.M., Kosinski L.A., Moore D.H. II, Smith-McCune K.K., et al. Angiogenesis, proliferation, and apoptosis in anal high-grade squamous intraepithelial lesions. Dis Colon Rectum. 43:(3):2000;346-352
19. Palefsky J.M., Holly E.A., Ralston M.L., Da Costa M., Greenblatt R.M. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis. 183:(3):2001;383-391
20. Holly E.A., Ralston M.L., Darragh T.M., Greenblatt R.M., Jay N., Palefsky J.M. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst. 93:(11):2001;843-849
21. Palefsky J.M., Holly E.A., Ralston M.L., Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis. 177:(2):1998;361-367
22. Palefsky J.M., Holly E.A., Ralston M.L., Arthur S.P., Jay N., Berry J.M., et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol. 17:(4):1998;320-326
23. Palefsky J.M., Holly E.A., Ralston M.L., Jay N., Berry J.M., Darragh T.M. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS. 12:(5):1998;495-503
24. Palefsky J.M., Holly E.A., Ralston M.L., Da Costa M., Bonner H., Jay N., et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr. 28:(5):2001;422-428
25. Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh T. Effect of HAART on incidence of anal intraepithelial neoplasia grade 3 among HIV-positive men who have sex with men. Presented at the Proceedings of the XIV International AIDS Conference, Barcelona, 2002.
26. Chang G.J., Berry J.M., Jay N., Palefsky J.M., Welton M.L. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum. 45:(4):2002;453-458
27. Marfing T.E., Abel M.E., Gallagher D.M. Perianal Bowen's disease and associated malignancies. Results of a survey. Dis Colon Rectum. 30:(10):1987;782-785
28. Klencke B.J., Palefsky J.M. Anal cancer: an HIV-associated cancer. Hematol Oncol Clin North Am. 17:(3):2003;859-872
29. Chin-Hong P.V., Palefsky J.M. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis. 35:(9):2002;1127-1134
30. Gutzmer R., Kaspari M., Vogelbruch M., Kiehl P., Kapp A., Werfel T., et al. Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry. Br J Dermatol. 147:(1):2002;160-165
31. Pehoushek J., Smith K.J. Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man. Arch Dermatol. 137:(1):2001;14-16
32. Jayne C.J., Kaufman R.H. Treatment of vulvar intraepithelial neoplasia 2/3 with imiquimod. J Reprod Med. 47:(5):2002;395-398
33. Diakomanolis E., Haidopoulos D., Stefanidis K. Treatment of high-grade vaginal intraepithelial neoplasia with imiquimod cream. N Engl J Med. 347:(5):2002;374
34. Berry J.M., Palefsky J.M. A review of human papillomavirus vaccines: from basic science to clinical trials. Front Biosci. 8:2003;S333-S345
35. Kaplan J.E., Masur H., Holmes K.K. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. Recommendations of the US Public Health Service and the Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep. 51:(RR-8):2002;1-52
36. Esiashvili N., Landry J., Matthews R.H. Carcinoma of the anus: strategies in management. Oncologist. 7:(3):2002;188-199
37. Bendell J.C., Ryan D.P. Current perspectives on anal cancer. Oncology [Huntingt]. 17:(4):2003;492-497. 502-3 [discussion: 503, 507-9]
38. Chawla A.K., Willett C.G. Squamous cell carcinoma of the anal canal and anal margin. Hematol Oncol Clin North Am. 15:(2):2001;321-344
39. Nigro N.D., Vaitkevicius V.K., Considine B. Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 17:(3):1974;354-356
40. Holland J.M., Swift P.S. Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy. Radiology. 193:(1):1994;251-254
41. Peddada A.V., Smith D.E., Rao A.R., Frost D.B., Kagan A.R. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 37:(5):1997;1101-1105
42. Hoffman R., Welton M.L., Klencke B., Weinberg V., Krieg R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys. 44:(1):1999;127-131
43. Cleator S., Fife K., Nelson M., Gazzard B., Phillips R., Bower M. Treatment of HIV-associated invasive anal cancer with combined chemoradiation. Eur J Cancer. 36:(6):2000;754-758
44. Place R.J., Gregorcyk S.G., Huber P.J., Simmang C.L. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum. 44:(4):2001;506-512
45. Kim J.H., Sarani B., Orkin B.A., Young H.A., White J., Tannebaum I., et al. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. Dis Colon Rectum. 44:(10):2001;1496-1502